Register
Login:
Share:
Email Facebook Twitter


Share Views Episode 9 - Early Stage Investment Opportunities


Immupharma Share Price (IMM)



Share Price Information for Immupharma (IMM)


Share Price: 37.00Bid: 36.00Ask: 38.00Change: 0.00 (0.00%)No Movement on Immupharma
Spread: 2.00Spread as %: 5.56%Open: 37.00High: 37.00Low: 37.00Yesterday’s Close: 37.00

Immupharma Plc Ord 10P

Immupharma is listed in the FTSE AIM All-Share
Immupharma is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
37.00

Share Price SpacerBid
36.00

Share Price SpacerAsk
38.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
79,115

Share Price SpacerOpen
37.00

Share Price SpacerHigh
37.00

Share Price SpacerLow
37.00

Share Price SpacerClose
37.00

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 121.78m £45.06m 10,000

52 Week High 48.25 52 Week High Date 2-JUN-2016
52 Week Low 19.75 52 Week Low Date 2-DEC-2015

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
6 63,750 15,365 -8.409 -4.40 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

28-Sep-16
12:36:33
37.50
11,968
Buy* 
36.00
38.00
4,488
Trade Type:
Ordinary

28-Sep-16
11:36:35
36.88
10,000
Sell* 
36.00
38.00
3,688
Trade Type:
Ordinary

28-Sep-16
11:34:49
36.50
50,000
Sell* 
36.00
38.00
18.25k
Trade Type:
Ordinary




View more Immupharma trades >>

Directors Deals for Immupharma (IMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
30-Apr-15Notification of Holding
Trade Notifier Information for Immupharma
Stephane Robert George Mery held the position of Non-Executive Director at Immupharma at the time of this trade.
 Stephane Robert George Mery
002259
24-Jan-13Sell
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
57GBX62,1690
24-Jan-12Buy
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
80GBX62,1690
View more Immupharma directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Tue 20:20KauriIMC37.00No Opinion
I was looking for IMC a while back & typed IMM walking to work. Anyway that was a stroke of luck as I think this company has good prospects.
Yes this is a headsup if you want to look at IMC, Immuron on the asx.
Mon 07:52sicilian_kanNews38.50No Opinion
IMM interim results due out this week.
Sun 18:01LostinfranceRE: Share Price38.50No Opinion
Olderandwiser, yes i completly agree, they have a order to sell. At 38-40 p
And it works well to them, they gain nothing from the price been higher as the following month they oay more for their shares,
But for us shareholders and prospective shareholders it holds the price back, and also publicity of a rising price,
They gain nothing if it gets to 50 p but imm do and the shareholders do,
If you understand my logic,
Sat 16:05IvyspiveyBoom38.50No Opinion
Yes gone back to work so less time for posting- not in but good to see some nice rises in likes of Redx and sure that I is only a matter of time here and one or two other bios
Fri 20:16boomorbustIvy38.50No Opinion
Good to hear from you and I completely agree.
Fri 19:59IvyspiveyRE: TimeNotTiming38.50No Opinion
Hi Boom
Just look in occasionally and nice points re trial progress- occasionally you may get a reference to patient recruitment being ahead/behind of expectations but normally very little info.so you watch progress on clinical trial site re.locatiobs etc.
I am far happier here even though I have about the same size holding in VAL- this is not just about range of products but at what stage you are at and also having a realistic view of market outcomes.

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Immupharma (IMM) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.